A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease
Abstract
Treatment with bismuth subsalicylate decreases the duration of diarrhea and is a safe and effective adjunct to oral rehydration therapy for infants and young children with acute watery diarrhea.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
chemotherapy
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
male
Child
Infant
preschool
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Body Weight
acute disease
diarrhea
multivariate analysis
fluid therapy
adjuvant
infantile / therapy
infantile / drug therapy*
pmid:8487823
doi:10.1056/nejm199306103282301
d figueroa-quintanilla
e salazar-lindo
e eyzaguirre-maccan
bismuth / administration & dosage
bismuth / therapeutic use*
organometallic compounds / administration & dosage
organometallic compounds / therapeutic use*
salicylates / administration & dosage
salicylates / therapeutic use*
Access
Citation
ID:
115440
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
115440
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
